BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9255152)

  • 1. FDG-PET appearance of pelvic Castleman's disease.
    Murphy SP; Nathan MA; Karwal MW
    J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT appearance of multicentric Castleman's disease mimicking lymphoma.
    Elboga U; Narin Y; Urhan M; Sahin E
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):142-4. PubMed ID: 22133346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT findings in a multicentric form of Castleman's disease.
    Halac M; Ergul N; Sager S; Demir A; Buyukpinarbasli N; Sonmezoglu K
    Hell J Nucl Med; 2007; 10(3):172-4. PubMed ID: 18084659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unicentric and multicentric Castleman's disease.
    Enomoto K; Nakamichi I; Hamada K; Inoue A; Higuchi I; Sekimoto M; Mizuki M; Hoshida Y; Kubo T; Aozasa K; Hatazawa J
    Br J Radiol; 2007 Jan; 80(949):e24-6. PubMed ID: 17267466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG positron emission tomographic imaging of thoracic Castleman's disease.
    Reddy MP; Graham MM
    Clin Nucl Med; 2003 Apr; 28(4):325-6. PubMed ID: 12642717
    [No Abstract]   [Full Text] [Related]  

  • 6. FDG-PET and diffusion-weighted MR imaging appearance in retroperitoneal Castleman's disease: a case report.
    Oida Y; Shimizu K; Mukai M; Imaizumi T; Nakamura M; Makuuchi H
    Clin Imaging; 2008; 32(2):144-6. PubMed ID: 18313580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fortuitous diagnosis of Castleman's disease by FDG-PET Scan during the follow-up of a renal cancer patient].
    Italiano A; Butori C; Verge M; Mouroux J; Thyss A
    Rev Med Interne; 2005 Jul; 26(7):597-9. PubMed ID: 15996575
    [No Abstract]   [Full Text] [Related]  

  • 8. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
    Lewis PJ; Salama A
    J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
    Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
    J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
    Mankoff DA; Thompson JA; Gold P; Eary JF; Guinee DG; Samlowski WE
    AJR Am J Roentgenol; 1997 Oct; 169(4):1049-50. PubMed ID: 9308463
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18-FDG PET in Paget's disease of bone.
    Cook GJ; Maisey MN; Fogelman I
    J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
    Iagaru A; Mari C; Sam Gambhir S
    Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging findings of angiofollicular lymphoid hyperplasia (Castleman's disease)].
    Horger M; Bares R; Wiefels J; Schöber W; Müssig K
    Rofo; 2007 Oct; 179(10):991-6. PubMed ID: 18240398
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
    Rosenfeld SS; Hoffman JM; Coleman RE; Glantz MJ; Hanson MW; Schold SC
    J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
    Goldberg MA; Lee MJ; Fischman AJ; Mueller PR; Alpert NM; Thrall JH
    Radiographics; 1993 Sep; 13(5):1047-62. PubMed ID: 8210589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
    Alavi A; Buchpiguel CA; Loessner A
    J Nucl Med; 1994 Oct; 35(10):1650-2. PubMed ID: 7931665
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
    Kapucu LO; Meltzer CC; Townsend DW; Keenan RJ; Luketich JD
    J Nucl Med; 1998 Jul; 39(7):1267-9. PubMed ID: 9669408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.